Treatment of diabetic retinopathy
**Core Concept**
Diabetic retinopathy is a microvascular complication of diabetes, characterized by damage to the retinal blood vessels, leading to vision impairment. The primary goal of treatment is to reduce the risk of progression and improve visual outcomes.
**Why the Correct Answer is Right**
The treatment of diabetic retinopathy involves a combination of laser photocoagulation, vitreoretinal surgery, and anti-vascular endothelial growth factor (VEGF) therapy. Laser photocoagulation is used to reduce edema and prevent further vision loss by ablating the ischemic retina. Anti-VEGF therapy, such as ranibizumab, is used to reduce vascular permeability and inhibit neovascularization. Vitreoretinal surgery may be required in cases of vitreous hemorrhage or retinal detachment.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while tight glycemic control is essential in managing diabetes, it is not a direct treatment for diabetic retinopathy.
**Option B:** This option is incorrect because while corticosteroids may be used to treat macular edema, they are not a primary treatment for diabetic retinopathy.
**Option C:** This option is incorrect because while nutritional supplements may be beneficial for patients with diabetic retinopathy, they are not a substitute for medical treatment.
**Clinical Pearl / High-Yield Fact**
It is essential to note that early detection and treatment of diabetic retinopathy can significantly improve visual outcomes and prevent vision loss. Regular eye exams are crucial for patients with diabetes to detect any retinopathy-related changes.
**Correct Answer:** A. Laser photocoagulation and anti-VEGF therapy are the mainstays of treatment for diabetic retinopathy.